| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |